Results 191 to 200 of about 668,253 (275)

SETD4 as a marker of disease burden and treatment response in childhood acute lymphoblastic leukemia<i>SETD4</i> as a marker of disease burden and treatment response in childhood acute lymphoblastic leukemia. [PDF]

Oncol Lett
Telles LAM, De Loyola MB, Sakamoto LHT, Rabello DDAR, Motoyama AB, Pittella-Silva F.   +5 more
europepmc   +1 more source

Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review). [PDF]

Oncol Rep
Li S, Ma Q, Lian K, Jiang Z, Ma Y.
europepmc   +1 more source

Gene expression and metadata based identification of key genes for lung cancer, COPD, and IPF using machine learning and statistical models. [PDF]

PLoS One
Yasmin MF, Hosen MF, Basar MA, Rahman A, Hasan M, Al Farid F, Karim HA, Miah ASM.   +7 more
europepmc   +1 more source

Heterogeneous nuclear ribonucleoprotein K in cancer biology and its therapeutic applications (Review). [PDF]

Mol Med Rep
Qin Y, Zhou Y.
europepmc   +1 more source

[Expression of Concern] 5‑Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene. [PDF]

Oncol Rep
Wang X, Chen E, Yang X, Wang Y, Quan Z, Wu X, Luo C.   +6 more
europepmc   +1 more source

Panomics Integration via Machine Learning Prioritizes TAF1D as a Therapeutic Vulnerability in Lung Adenocarcinoma. [PDF]

Hum Mutat
Ding L, Xu Q, Liu D, Wu J, Cai X, Xu F, Ma S, Wang H, Shi Y.   +8 more
europepmc   +1 more source

Generation of Allogeneic CAR‐T Circumvents Functional Deficits in Patient‐Derived Autologous Product for Glioblastoma

International Journal of Cancer, EarlyView.
Clinical trials of chimeric antigen receptor T‐cell (CAR‐T) therapies in glioblastoma have shown limited clinical benefits. Whether this may be explained by the basal quality of CAR‐T products, which are currently generated using patient, autologous T‐cells, has been little explored.
Sabra K. Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, William T. Maich, Alisha Anand, Oliver Y. Tang, Minomi K. Subapanditha, Zahra Alizada, Yujin Suk, Manoj Singh, Kui Zhai, Aapti Khanna, Benjamin Brakel, Vassil Dimitrov, Zoya Tabunshchyk, Katie Chan, Kevin R. Brown, Parvez Vora, Donald M. O'Rourke, Zev A. Binder, Chitra Venugopal, Jason Moffat, Sheila K. Singh   +22 more
wiley   +1 more source

Endogenous protein tagging coupled with a CRISPR screening approach identifies UBE3C as a potential MYC oncogene regulator. [PDF]

Sci Rep
Seibert M, Kurrle N, Kaleab S, Wempe F, von Metzler I, Serve H, Schnütgen F.   +6 more
europepmc   +1 more source

Diagnostic accuracy of phosphatase and tensin homolog loss in differentiating between atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia and non‐atypical endometrial hyperplasia: A systematic review and meta‐analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Accurate distinction between atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (AH/EIN) and non‐atypical endometrial hyperplasia (EH) determines whether patients require hysterectomy or can be managed conservatively.
Kristina Shcherbatiuk, Steffi Bultmann, Thomas Karn, Khayal Gasimli, Peter Wild, Sven Becker, Morva Tahmasbi Rad   +6 more
wiley   +1 more source

Role of MeCP2 in Shaping the Histopathological Heterogeneity of Ampullary Carcinoma. [PDF]

Acta Histochem Cytochem
Ohno T, Kitazawa R, Haraguchi R, Taniwaki M, Takaoka Y, Hiraki-Kamon K, Kato H, Kitazawa S.   +7 more
europepmc   +1 more source